USA - New York Stock Exchange - NYSE:CL - US1941621039 - Common Stock
The current stock price of CL is 79.94 USD. In the past month the price increased by 3.75%. In the past year, price decreased by -15.16%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PG | PROCTER & GAMBLE CO/THE | 21.4 | 344.53B | ||
| KMB | KIMBERLY-CLARK CORP | 15.78 | 36.02B | ||
| CHD | CHURCH & DWIGHT CO INC | 24.66 | 20.31B | ||
| CLX | CLOROX COMPANY | 15.83 | 12.98B | ||
| REYN | REYNOLDS CONSUMER PRODUCTS I | 15.19 | 5.18B | ||
| WDFC | WD-40 CO | 33.94 | 2.67B | ||
| CENT | CENTRAL GARDEN & PET CO | 12.39 | 2.12B | ||
| CENTA | CENTRAL GARDEN AND PET CO-A | 11.21 | 1.92B | ||
| SPB | SPECTRUM BRANDS HOLDINGS INC | 10.44 | 1.35B | ||
| ENR | ENERGIZER HOLDINGS INC | 5.48 | 1.19B | ||
| ODC | OIL-DRI CORP OF AMERICA | 11.09 | 783.97M |
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. The company is headquartered in New York City, New York and currently employs 34,000 full-time employees. The company is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
COLGATE-PALMOLIVE CO
300 Park Ave
New York City NEW YORK 10022 US
CEO: Noel R. Wallace
Employees: 34000
Phone: 12123102000
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. The company is headquartered in New York City, New York and currently employs 34,000 full-time employees. The company is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
The current stock price of CL is 79.94 USD. The price decreased by -0.56% in the last trading session.
COLGATE-PALMOLIVE CO (CL) has a dividend yield of 2.6%. The yearly dividend amount is currently 2.19.
CL has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The Revenue of COLGATE-PALMOLIVE CO (CL) is expected to grow by 0.84% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
COLGATE-PALMOLIVE CO (CL) has a market capitalization of 64.44B USD. This makes CL a Large Cap stock.
The outstanding short interest for COLGATE-PALMOLIVE CO (CL) is 1.7% of its float.
ChartMill assigns a technical rating of 2 / 10 to CL. When comparing the yearly performance of all stocks, CL is a bad performer in the overall market: 75.68% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to CL. While CL has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months CL reported a non-GAAP Earnings per Share(EPS) of 3.65. The EPS increased by 2.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.46% | ||
| ROA | 16.6% | ||
| ROE | 339.6% | ||
| Debt/Equity | 8.54 |
30 analysts have analysed CL and the average price target is 88.82 USD. This implies a price increase of 11.1% is expected in the next year compared to the current price of 79.94.
For the next year, analysts expect an EPS growth of 4.87% and a revenue growth 0.84% for CL